Andrea Frey

Andrea serves as Co-Chair of the firm’s Digital Health and Reproductive Health Practices, where she advises a broad range of clients at the intersection of health care innovation, regulatory compliance, and transactional matters. She focuses on guiding health care providers, technology companies, health information exchanges, and other industry stakeholders through the complex legal and regulatory landscape that governs modern care delivery.

Andrea has deep experience counseling clients on the development, implementation, and operation of digital health solutions—including telemedicine platforms, artificial intelligence in clinical care, and data-driven models. She offers strategic regulatory advice on health data privacy and security, patient consent, corporate practice of medicine restrictions, and compliance with federal and state fraud and abuse laws. With specialized expertise in data privacy, she regularly advises on legal strategies and best practices for protecting and leveraging health data, including the use of limited data sets and data licensing agreements.

In addition to her regulatory work, Andrea maintains a robust transactional practice. She represents clients in a wide range of health care transactions, including mergers, acquisitions, joint ventures, and strategic affiliations. Her skills include conducting corporate and regulatory due diligence and negotiating key agreements, such as asset and stock purchase agreements, operations transfer agreements, management services agreements, and professional services agreements. Her transactional insight is especially valuable to client’s pursuing growth through technology-enabled virtual care models.

Andrea also advises on a broad spectrum of health care compliance and operational issues, including clinical research requirements, medical staff governance, provider licensure and credentialing, scope-of-practice requirements, and medico-legal matters. She brings a thoughtful, solutions-oriented approach to helping clients manage regulatory risk while advancing innovative, patient-centered care.